Sexual Medicine Society of North America, Inc.

Friday, November 9, 2018
Morning
07:00 a.m. - 08:00 a.m.
Location: Americana Ballroom Salon 1&2
SMSNA Business Meeting (members only) - Including Breakfast
08:00 a.m. - 09:00 a.m.
Location: Americana Ballroom Salon 3
ISSM Session
Moderator: Luiz Otavio Torres, MD
08:00 a.m. - 08:05 a.m.
Introduction to ISSM and WMSM 2020
Speaker: Luiz Otavio Torres, MD & Yoshikazu Sato, MD, PhD
08:05 a.m. - 08:25 a.m.
The Best of the 21st World Meeting on Sexual Medicine 2018
Speaker: Wayne Hellstrom, MD
08:25 a.m. - 08:45 a.m.
What is Hot and What's Not in Female Sexual Medicine: Separating Fact from Fiction
Speaker: Michael Krychman, MD
08:45 a.m. - 09:00 a.m.
Use and Abuse of Testosterone and other Steroids: What do we know?
Speaker: Luiz Otavio Torres, MD
09:00 a.m. - 10:00 a.m.
Location: Americana Ballroom Salon 3
ESSM Session: What's New in MSD Treatment? The European Perspective
Moderator: Hartmut Porst, MD & Yacov Reisman, MD
09:00 a.m. - 09:15 a.m.
Pro & Con of Low-Intensity Shockwave therapy (LISWT) for Erectile Dysfunction
Speaker: Yacov Reisman, MD
09:15 a.m. - 09:30 a.m.
New Developments in Premature Ejaculation Treatment
Speaker: Ege Can Serefoglu, MD
09:30 a.m. - 09:45 a.m.
News on Peyronie's Disease
Speaker: Carlo Bettocchi, MD
09:45 a.m. - 09:55 a.m.
ESSM Future Activities
Speaker: Yacov Reisman, MD
09:55 a.m. - 10:00 a.m.
Q&A
10:00 a.m. - 10:30 a.m.
Location: Americana Ballroom Salon 4
Coffee Break
10:05 a.m. - 10:30 a.m.
Location: Americana Ballroom Foyer - E-Poster Station 1
E-Poster Session 6 - Female Sexual Dysfunction/Miscellaneous 2
Moderator: Sherita King, MD
10:05 a.m. - 10:08 a.m.
Bremelanotide for Hypoactive Sexual Desire Disorder: Age and Weight Subgroup Efficacy Analyses (RECONNECT Studies) (#215)
Speaker: Anita Clayton
10:08 a.m. - 10:11 a.m.
Vaginal Diazepam to Treat Pelvic Floor Pain (#216)
Speaker: Alexandra Berger
10:11 a.m. - 10:14 a.m.
Pilates Exercise for Treatment of Female Sexual Dysfunction (#217)
Speaker: Ahmet Gokce, MD
10:14 a.m. - 10:17 a.m.
The Efficacy of Vaginal Moisturizers Composed of β-glucans in Treatment of Vulvo-vaginal Atrophy with Post-menopausal Women (#218)
Speaker: Sun Tae Ahn, MD
10:17 a.m. - 10:20 a.m.
Female Residents are as Successful as Male Counterparts in Discussions Leading to Penile Implant Surgery (#219)
Speaker: Andrew Kramer, MD
10:20 a.m. - 10:23 a.m.
SEXpertise - Approach to Sexual Health in the Medical Consultation Setting (#220)
Speaker: Carla Rodrigues
10:23 a.m. - 10:26 a.m.
A Very Rare Tumor of the Spermatic Cord Found During an Infertility Consultation: The Malignant Fibrous Histiocytoma (#221)
Speaker: Andreas Bannowsky
10:05 a.m. - 10:30 a.m.
Location: Americana Ballroom Foyer - E-Poster Station 2
E-Poster Session 7 - Erectile Dysfunction Surgical 3
Moderator: Charles Welliver, MD
10:05 a.m. - 10:08 a.m.
Safety Tab: A Novel Approach to Intraoperative Inflatable Penile Prosthesis (IPP) Cylinder Resizing (#222)
Speaker: Joseph Sarcona
10:08 a.m. - 10:11 a.m.
Penile Prosthesis Salvage with Saline or Antibiotic Solutions: A Review of the Different Irrigation Solutions, their Rational, and Effects in Wound Healing (#223)
Speaker: Dayron Rodríguez
10:11 a.m. - 10:14 a.m.
Surgeons should not Fear Performing Additional Urologic Procedures at the Time of Penile Prosthesis Implantation (#224)
Speaker: Jeffrey D. Campbell
10:14 a.m. - 10:17 a.m.
Inflatable Penile Prosthesis in the Ambulatory Surgical Setting: Outcomes from a Large Urological Group Practice (#225)
Speaker: Aaron Weinberg
10:17 a.m. - 10:20 a.m.
Determine Penile Oxygen Saturation and Blood Gases after Vacuum Erectile Device like Important Factor in Penile Rehabilitation (#226)
Speaker: Sergey Kotov
10:20 a.m. - 10:23 a.m.
Penile Rehabilitation after Nerve-sparing Radical Prostatectomy (#227)
Speaker: Sergei Kotov
10:23 a.m. - 10:26 a.m.
Developing a Catalog of Non-infectious Distal Cylinder Complications Requiring Revision Penile Implant Surgery (#228)
Speaker: Bruce Kava, MD
10:26 a.m. - 10:29 a.m.
Sexual Satisfaction and Ease of Use Influences Overall Inflatable Penile Prosthesis Patient Satisfaction (#229)
Speaker: Daniel Nassau
10:05 a.m. - 10:30 a.m.
Location: Americana Ballroom Foyer - E-Poster Station 3
E-Poster Session 8 - Androgens/Steroids
Moderator: Faysal Yafi, MD, FRCSC
10:05 a.m. - 10:08 a.m.
Glucose, Glycated Hemoglobin A Levels and Erectile Function in 16 Hypogonadal Men with Type 2 Diabetes (T2DM) Before and After Testosterone Therapy (#230)
Speaker: Karim Sultan Haider
10:08 a.m. - 10:11 a.m.
Natesto Effects on Reproductive Hormones and Semen Parameters: Results from an ongoing Single Center Investigator-initiated Phase IV Clinical Trial (#231)
Speaker: Thomas Masterson
10:11 a.m. - 10:14 a.m.
Effects of Androgen Replacement Therapy and Once-a-day Tadalafil on Loss of Vigor & Energy (LOVE) Syndrome in Men’s Health Clinic (#232)
Speaker: Yoshikazu Sato, MD, PhD
10:14 a.m. - 10:17 a.m.
Human Chorionic Gonadotropin (hCG) Monotherapy for the Treatment of Symptoms of Hypogonadism in Men with Total Testosterone > 300 ng/Dl (#233)
Speaker: Vinayak Madhusoodanan
10:17 a.m. - 10:20 a.m.
Testosterone-Replacement Therapy in Patients with Baseline Low-normal to Normal Testosterone Levels and Hypogonadal Symptoms (#234)
Speaker: Nelson Bennett, MD, FACS
10:20 a.m. - 10:23 a.m.
Can a Dietary Supplement Support Sperm Motility and Sperm Quality? (#235)
Speaker: Michael Krychman, MD
10:23 a.m. - 10:26 a.m.
Long-standing Diabetes and Poor Glycemic Control Result in Worse Peyronie's Curvature (#236)
Speaker: Dorota Hawksworth
10:30 a.m. - 12:00 p.m.
Location: Poinciana 1&2
Mental Health Session: Towards a Transdisciplinary Approach to Sexual Medicine and Sexual Health: Addressing Sexual Problems from a Biopsychosocial Perspective
Moderator: Michael Perelman, PhD & Daniela Wittmann, PhD, LMSW
10:30 a.m. - 10:40 a.m.
Updates in Mental Health - Most Noteworthy Literature from 2017-2018
Speaker: Chiara Acquati, PhD, MSW
10:40 a.m. - 10:50 a.m.
Addressing Sexual Health after Spinal Cord Injury: The Sexual Rehabilitation Framework
Speaker: Stacy Elliott, MD
10:50 a.m. - 11:00 a.m.
The Impact of Infertility on Sexuality
Speaker: Elizabeth Grill, PhD
11:00 a.m. - 11:10 a.m.
The Impact of Sexual Dysfunction on Relationships (#007)
Speaker: Jack Andrews
11:10 a.m. - 11:20 a.m.
Motivational Interviewing for Sexual Health Risky Behaviors (#008)
Speaker: Carla Rodrigues
11:20 a.m. - 11:30 a.m.
Double Stigma: Masculinity Meets Sexual Dysfunction in Chronic Illness
Speaker: Andrew Matthew, PhD
11:30 a.m. - 11:40 a.m.
When to Refer Urology, Andrology and Gynecology Patients to Sexual Health or Mental Health Providers?
Speaker: Annamaria Giraldi, MD, PhD
11:40 a.m. - 11:50 a.m.
The Impact of Pelvic Pain on Sexuality
Speaker: Melissa Farmer, PhD
11:50 a.m. - 12:00 p.m.
Q&A
10:30 a.m. - 12:00 p.m.
Location: Americana Ballroom Salon 3
Male Sexual Dysfunction
Moderator: Arthur Burnett II, MD & Doron Stember, MD
10:30 a.m. - 10:40 a.m.
Updates in Male Sexual Health - Most Noteworthy Literature from 2017-2018
Speaker: Casey McCraw, MD
10:40 a.m. - 10:55 a.m.
A Treatment Algorithm for Healthy Young Men with Erectile Dysfunction
Speaker: Laurence Levine, MD
10:55 a.m. - 11:10 a.m.
Crossing the Intersection Between Men's Sexual Health and Men's Health
Speaker: Bruce Kava, MD
11:10 a.m. - 11:30 a.m.
Q&A
11:30 a.m. - 12:00 p.m.
5th Annual Robert Krane Lecture: From the Nitric Oxide/cGMP Pathway and gene/PDE5i Therapy, to Stem Cells in Sexual Medicine Research: A Glimpse on an Ongoing Journey
Speaker: Nestor Gonzalez-Cadavid, PhD
10:30 a.m. - 12:00 p.m.
Location: Poinciana 3&4
Transgender
Moderator: Maurice Garcia, MD, MAS & Stanton Honig, MD
10:30 a.m. - 10:40 a.m.
Updates in Transgender Medicine - Most Noteworthy Literature from 2017-2018
Speaker: Dmitriy Nikolavsky, MD
10:40 a.m. - 10:50 a.m.
Feminizing Genital Gender Affirming Surgery and Sexual Function: Vaginoplasty with Creation of a Vaginal Canal and Without Creation of a Vaginal Canal
Speaker: Stanton Honig, MD
10:50 a.m. - 11:00 a.m.
Feminizing Genital Gender Affirming Surgery and Sexual Function: Strategies to Optimize the Hospital Pathway
Speaker: Polina Reyblat, MD
11:00 a.m. - 11:10 a.m.
There’s More to Surgery than a Steady Hand: Patient Reported Outcomes in Gender Affirming Surgery (#009)
Speaker: Alexandra Millman
11:10 a.m. - 11:20 a.m.
A Novel Pre-surgery Counseling Aid for Transgender Patients Undergoing MtoF Genital Gender Affirming Surgery with Vaginoplasty to Help Manage Patient Expectations and to Facilitate Patient’s Choice of Surgery (Full-Depth or Shallow-Depth Vaginoplasty) (#010)
Speaker: Maurice Garcia, MD, MAS
11:20 a.m. - 11:30 a.m.
Masculinizing Genital Gender Affirming Surgery and Sexual Function: Phallourethroplasty Using Radial Artery Forearm Flap and Anterior Lateral Thigh Flap Techniques: Strategies to Optimize Sexual Function and Common Urinary Tract Complications
Speaker: Maurice Garcia, MD, MAS
11:30 a.m. - 11:40 a.m.
Masculinizing Genital Gender Affirming Surgery and Sexual Function: Metoidioplasty with and without Urethral Lengthening
Speaker: Ervin Kocjancic, MD
11:40 a.m. - 11:55 a.m.
Strategies to Good Clinical Outcomes by Optimizing Proper Patient Selection and Management of Surgery Related Expectations: Lessons Learned from the Mental Health Professional and from Surgical Management
Speaker: Maurice Garcia, MD, MAS
11:55 a.m. - 12:00 p.m.
Q&A
Afternoon
12:00 p.m. - 01:30 p.m.
Location: Americana Ballroom Salon 1&2
Industry Sponsored Lunch Symposium
01:30 p.m. - 02:30 p.m.
Location: Americana Ballroom Salon 3
Female Sexual Dysfunction
Moderator: Tami Rowen, MD, MS, FACOG & Maureen Whelihan, MD, FACOG
01:30 p.m. - 01:40 p.m.
Updates in Female Sexual Dysfunction - Most Noteworthy Literature from 2017-2018
Speaker: Seth Cohen, MD, MPH
01:40 p.m. - 01:50 p.m.
Process of Care for Management of Women with HSDD
Speaker: Irwin Goldstein, MD
01:50 p.m. - 02:00 p.m.
Kissing, Cuddling, and Massage at Most Recent Sexual Event: Findings from a U.S. Nationally Representative Probability Sample (#011)
Speaker: Tsung-Chieh Fu
02:00 p.m. - 02:10 p.m.
Lasers and Lubricants: Which Ones are Best for my Practice and my Patients?
Speaker: Ashley Tapscott, DO
02:10 p.m. - 02:20 p.m.
What's HOT in Female Sexual Dysfunction
Speaker: Michael Krychman, MD
02:20 p.m. - 02:30 p.m.
Q&A
01:30 p.m. - 03:30 p.m.
Location: Poinciana 1&2
Peyronie's Disease - Moderated Posters
Moderator: Bruce Kava, MD & Hartmut Porst, MD
01:50 p.m. - 01:55 p.m.
Peyronie’s Disease Pictorial Intake Form - A Novel Tool for Evaluating Penile Curvature (#105)
Speaker: Mohamed Adnan
01:55 p.m. - 02:00 p.m.
Cost Effectiveness of Peyronie’s Disease Therapies: A Comparison of RestoreX Penile Traction Therapy, Collagenase Clostridium Histolyticum, and Surgery (#106)
Speaker: Kevin Wymer
02:00 p.m. - 02:05 p.m.
Efficacy of Combined Xiaflex and RestoreX Penile Traction Therapy in Men with Peyronie’s Disease (#107)
Speaker: Manaf Alom
02:05 p.m. - 02:10 p.m.
Intralesional Collagenase Clostridium Histolyticum Causes Meaningful Improvement in Men with Peyronie’s Disease: The Results of a Multi-institutional Analysis (#108)
Speaker: Hoang Minh Tue Nguyen
02:10 p.m. - 02:15 p.m.
Penile Plication For Severe Peyronie's Deformities Has Similar Patient Reported Outcomes To Mild Cases (#109)
Speaker: Michael Davenport
02:15 p.m. - 02:20 p.m.
Safety and Efficacy of Collagenase Clostridium Histolyticum in Peyronie’s Disease Men with Ventral Curvatures (#110)
Speaker: Manaf Alom
02:20 p.m. - 02:25 p.m.
Long-term Safety and Curvature Deformity Characterization in Patients Previously Treated with Collagenase Clostridium Histolyticum for Peyronie’s Disease (#111)
Speaker: Irwin Goldstein, MD
02:25 p.m. - 03:30 p.m.
Adherence to Xiaflex (collagenase clostridium histolyticum) Label Recommendations and Provider Satisfaction: A Survey of ISSM Members (#112)
Speaker: Alex Galante
02:30 p.m. - 02:35 p.m.
Long-term Complete Outcomes of Concurrent Tachosil Grafting with Inflatable Penile Prosthesis Placement (#113)
Speaker: Joshua Ring
02:35 p.m. - 02:40 p.m.
The Impact of Intralesional Xiaflex On Psychosocial Outcomes in Men with Peyronie’s Disease (PD) (#114)
Speaker: Bruno Nascimento
02:40 p.m. - 02:45 p.m.
Incision and Buccal Mucosa Grafting in the Treatment of Peyronie's Disease (#115)
Speaker: Sergei Kotov
02:45 p.m. - 02:50 p.m.
Evaluation of Complication Rates Related to Surgical Management of Concurrent Erectile Dysfunction and Peyronie’s Disease: National Multi-institutional Analysis of the National Surgical Quality Improvement Program (NSQIP) Database (#116)
Speaker: Mahmoud Khalil
02:50 p.m. - 02:55 p.m.
The Effect of Adjunct Mechanical Traction on Penile Length in Men Undergoing Primary Treatment for Peyronie's Disease: A Systematic Review and Meta-analysis (#117)
Speaker: Nora Haney
02:55 p.m. - 03:00 p.m.
Rates of Completion and Reasons for Dropout from a Standard Eight-Injection Course of Collagenase Clostridium Histolyticum Therapy (#118)
Speaker: Arash Amighi
01:30 p.m. - 03:30 p.m.
Location: Poinciana 3&4
Androgens - Moderated Posters
Moderator: Abraham Morgentaler, MD & Cigdem (Cori) Tanrikut, MD
01:50 p.m. - 01:55 p.m.
Staying Above Water: The Impact of Testosterone and Growth Hormone Secretagogues on Fluid Retention Parameters (#119)
Speaker: Alexander J. Tatem
01:55 p.m. - 02:00 p.m.
Effect of Testosterone Enanthate (TE) on 24-hour Ambulatory Blood Pressure (ABP) Vary by Hypertension (HTN) Diagnosis and Treatment (#120)
Speaker: Mohit Khera, MD
02:00 p.m. - 02:05 p.m.
Efficacy and Safety of a Mixed Extract of Trigonella foenum-graecum Seed and Lespedeza cuneata in the Treatment of Testosterone Deficiency Syndrome: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial (#121)
Speaker: Nam Cheol Park
02:05 p.m. - 02:10 p.m.
Diagnosis and Management of Testosterone Deficiency – Comparison of Current Guidelines (#122)
Speaker: Jethro Kwong
02:10 p.m. - 02:15 p.m.
Total Testosterone Level and Infiltrating Lymphocyte Density within the Prostate: Is There an Optimal Window? (#123)
Speaker: Andrew Gabrielson
02:15 p.m. - 02:20 p.m.
Failure of Testosterone Replacement Therapy to Improve Symptoms Correlates with Burden of Systemic Conditions (#124)
Speaker: Sarah Vij
02:20 p.m. - 02:25 p.m.
The Relationship Between PSA and Total Testosterone Levels in Men with Low, Intermediate and High Grade Prostate Cancer (#125)
Speaker: Helen Levey Bernie, DO, MPH
02:25 p.m. - 02:30 p.m.
Testosterone Imposters: An Analysis of Popular Online Testosterone Boosting Supplements (#126)
Speaker: Adithya Balasubramanian
02:30 p.m. - 02:35 p.m.
Misinformation of Testosterone Replacement on the Internet (#127)
Speaker: Denise Asafu-Adjei
02:35 p.m. - 02:40 p.m.
Treatment of Estrogen Levels in the Management of Hypogonadism: An Anonymous Survey of ISSM Members (#128)
Speaker: Nannan Thirumavalavan, MD, BA
02:40 p.m. - 02:45 p.m.
Treatment of Hypogonadism in the Solid Organ Transplant Recipient: A Case Series from a High-volume Andrology Clinic (#129)
Speaker: Nannan Thirumavalavan, MD, BA
02:45 p.m. - 02:50 p.m.
Torimifene Citrate Improves High-Density Lipoprotein Levels in Men on Testosterone Replacement Therapy (#130)
Speaker: Alexander J. Tatem
02:50 p.m. - 02:55 p.m.
Differences in Androgen Levels and Sexual Function between North American and European Men (#131)
Speaker: Mahmoud Mima
02:55 p.m. - 03:00 p.m.
Erectile and Urinary Function and Quality of Life Improve in Hypogonadal Mmen with Osteoporosis Under Long-Term Testosterone Therapy with Testosterone Undecanoate Injections (TU) in Comparison to an Untreated Control Group: 10-Year Data from a Registry Study in a Urological Setting (#132)
Speaker: Ahmad Haider
03:00 p.m. - 03:05 p.m.
Larger Than Life: Motivations for Bodybuilding and Anabolic Steroid Usage (#133)
Speaker: Jonathan Beilan
03:05 p.m. - 03:10 p.m.
Impaired Sleep is Associated with Low Testosterone in US Adult Males: Results from the National Health and Nutrition Examination Survey (#134)
Speaker: Premal Patel, MD
03:10 p.m. - 03:15 p.m.
Reference Intervals for Serum Testosterone Levels in Korean: Results from Large Health Examination Data (#135)
Speaker: Myong Kim
03:15 p.m. - 03:20 p.m.
Cross-sectional Association Between Testosterone and Metabolic Syndrome (#136)
Speaker: Yu Seob Shin
02:30 p.m. - 03:30 p.m.
Location: Americana Ballroom Salon 3
Erectile Dysfunction - Medical
Moderator: Tobias Kohler, MD, MPH; Mustafa Usta, MD & Run Wang, MD, FACS
02:30 p.m. - 02:40 p.m.
Updates in Erectile Dysfunction (Medical) - Most Noteworthy Literature from 2017-2018
Speaker: Helen Levey Bernie, DO, MPH
02:40 p.m. - 02:55 p.m.
How to Conduct and Interpret Duplex Doppler Ultrasonography in Med with ED
Speaker: Gerald Brock, MD
02:55 p.m. - 03:05 p.m.
Alternative ED Therapies - LiSWT, PRP, Stem Cells: Advancement in the Era of Regulation
Speaker: Gregory Broderick, MD
03:05 p.m. - 03:15 p.m.
Vibrator Stimulation: Is There a Role for ED?
Speaker: Serge Carrier, MD
03:15 p.m. - 03:30 p.m.
AUA Erectile Dysfunction Guidelines
Speaker: Hossein Sadeghi-Nejad, MD, FACS
03:30 p.m. - 04:00 p.m.
Location: Americana Ballroom Salon 4
Coffee Break
03:35 p.m. - 04:00 p.m.
Location: Americana Ballroom Foyer - E-Poster Station 1
E-Poster Session 9 - Erectile Dysfunction Surgical 4
Moderator: Billy Cordon, MD
03:35 p.m. - 03:38 p.m.
Bibliometric Analysis of Erectile Dysfunction Publications in Urology and Sexual Medicine Journals (#237)
Speaker: Michael Rezaee
03:38 p.m. - 03:41 p.m.
Grumpy Old Men? The Association Between Age and Satisfaction in Men Undergoing Placement of Inflatable Penile Prostheses (#238)
Speaker: Adam Miller
03:41 p.m. - 03:44 p.m.
Addition of Multiple Hemostatic Agents Improves Hematoma Formation and Outcomes in Penile Implant Surgery (#239)
Speaker: Andrew Kramer, MD
03:44 p.m. - 03:47 p.m.
Film Study and Comprehensive Video Analysis to Improve Surgical Technique with Specific Outcome Metrics (#240)
Speaker: Andrew Kramer, MD
03:47 p.m. - 03:50 p.m.
Simulation Training in Prosthetic Urology: Cadaveric Laboratory Training Improves Trainees’ Surgical Confidence and Knowledge (#241)
Speaker: Dayron Rodriguez
03:50 p.m. - 03:53 p.m.
Commercial Insurance Coverage for Inflatable Penile Prosthesis at a Tertiary Care Center (#242)
Speaker: John Masterson
03:53 p.m. - 03:56 p.m.
Closed Suction Drain Outputs at 12 and 24 Hours After Primary Three-piece Inflatable Penile Prosthesis Surgery (#244)
Speaker: Dayron Rodriquez
03:35 p.m. - 04:00 p.m.
Location: Americana Ballroom Foyer - E-Poster Station 2
E-Poster Session 10 - Urinary/BPH/Incontinence 1
Moderator: Amy Pearlman, MD
03:35 p.m. - 03:38 p.m.
Rezūm Prostate Ablation for Large Gland (≥80 grams) Prostates (#245)
Speaker: Ross Avant
03:38 p.m. - 03:41 p.m.
Urethral Bulking at Time of Artificial Urinary Sphincter Implantation (#246)
Speaker: Dorota Hawksworth
03:41 p.m. - 03:44 p.m.
Comparison of Complication Rates Related to Penile Prosthesis and Advance™ Male Slings Versus Penile Prosthesis and Artificial Urinary Sphincters: National Multi‑institutional Analysis of NSQIP Database (#247)
Speaker: Omer Raheem
03:44 p.m. - 03:47 p.m.
Single-incision Urethral Closure and Penile Prosthesis Removal (#248)
Speaker: Jonathan Beilan
03:47 p.m. - 03:50 p.m.
Efficacy and Safety of Holmium Laser Enucleation of Prostate (HoLEP) in Patients with Underlying Neurologic Disease (#249)
Speaker: Myong Kim
03:50 p.m. - 03:53 p.m.
Single Perineal Incision for Artificial Urinary Sphincter: An Analysis of Technique, Outcomes, and Experience (#250)
Speaker: Nahid Punjani
03:35 p.m. - 04:00 p.m.
Location: Americana Ballroom Foyer - E-Poster Station 3
E-Poster Session 11 - Urinary/BPH/Incontinence 2
Moderator: Ashley Tapscott, DO
03:35 p.m. - 03:38 p.m.
Search for a Rational Supplement Combination for Prostatism and Erectile Dysfunction (#251)
Speaker: Robert Pyke
03:38 p.m. - 03:41 p.m.
Is Sexual Function Better Preserved After Water Vapor Thermal Therapy or Medical Therapy For Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia? (#252)
Speaker: Nikhil Gupta
03:41 p.m. - 03:44 p.m.
Descriptive Outcomes of Patients Undergoing UroLift for Extended Indications (#253)
Speaker: Jacob Jipp
03:44 p.m. - 03:47 p.m.
A Prospective Evaluation of Diabetic Patients Receiving Inflatable Penile Prosthesis (#254)
Speaker: Alfredo Suarez-Sarmiento
03:47 p.m. - 03:50 p.m.
Long-term Outcomes of Permanent Urethral Ligation (PUL) for Men with Recurrent Artificial Urinary Sphincter (AUS) Erosion (#255)
Speaker: Ryan Baker
03:50 p.m. - 03:53 p.m.
A Novel Prostatic Block for Minimally Invasive Treatment for BPH (#256)
Speaker: Joel Hillelsohn
03:53 p.m. - 03:56 p.m.
Use of a Suprapubic Tube at the Time of Artificial Urinary Sphincter Placement: A Strategy to Avoid Urethral Catheterization in the “At Risk” Patient (#257)
Speaker: Christopher Graziano, MD
04:00 p.m. - 05:30 p.m.
Location: Americana Ballroom Salon 3
Androgens
Moderator: Serge Carrier, MD; Jason Jameson, MD & Hui Jiang, MD
04:00 p.m. - 04:10 p.m.
Updates in Androgens - Most Noteworthy Literature from 2017-2018
Speaker: Anand Shridharani, MD
04:10 p.m. - 04:20 p.m.
Controversies in Testosterone Therapies: What Have We Learned from the Testosterone Trials
Speaker: Mohit Khera, MD
04:20 p.m. - 04:30 p.m.
Incidence and Characteristics of Men at High Risk for Sleep Apnea in a High Volume Andrology Clinic (#012)
Speaker: Alexander J. Tatem
04:30 p.m. - 04:40 p.m.
Mortality, Incident Myocardial Infarction and Stroke in Hypogonadal Men with a Pre-existing Cardiovascular Disease With and Without Testosterone Therapy: Real-life Evidence from a 10-Year Registry (#013)
Speaker: Karim Sultan Haider
04:40 p.m. - 04:55 p.m.
How to Treat Low Testosterone: Identification, Lab Testing, Medication Choice, Follow-up
Speaker: Martin Miner, MD
04:55 p.m. - 05:05 p.m.
Debate: Should Testosterone Therapy Only Be Used in Classical Hypogonadism: PRO
Speaker: Lawrence Jenkins, MD, MBA
05:05 p.m. - 05:15 p.m.
Debate: Should Testosterone Therapy Only Be Used in Classical Hypogonadism: CON
Speaker: Kelly Chiles, MD
05:15 p.m. - 05:30 p.m.
AUA Testosterone Guidelines
Speaker: Landon Trost, MD
04:00 p.m. - 05:30 p.m.
Location: Poinciana 1&2
Female Sexual Dysfunction - Moderated Posters
Moderator: Don S. Dizon, MD & Sherita King, MD
04:15 p.m. - 04:20 p.m.
Three-site Prospective Double-blind, Sham-controlled Pilot Study to Examine the Safety and Efficacy of CO2 Fractional Laser Therapy to the Vestibule in Women with Distress from Vestibulodynia: Interim Analysis of Vulvoscopic Photographic Images (#137)
Speaker: Irwin Goldstein, MD
04:20 p.m. - 04:25 p.m.
Bremelanotide for Hypoactive Sexual Desire Disorder in the RECONNECT Study: Analysis of Co-primary Endpoints According to Baseline FSFI Total Scores (#138)
Speaker: Anita Clayton
04:25 p.m. - 04:30 p.m.
Effects of Alcohol Administered with Flibanserin in Healthy Premenopausal Women: A Randomized, Double-Blind, Single-Dose, Seven-way Crossover Study (#139)
Speaker: James Simon
04:30 p.m. - 04:35 p.m.
The Impact of the Timing of Alcohol Consumption on the Safety and Tolerability of Flibanserin (#140)
Speaker: James Simon
04:35 p.m. - 04:40 p.m.
"If Everyone Else is Having This Talk with Their Doctor, Why am I Not Having This Talk with Mine?": The Experiences of Sexuality and Sexual Health Education of Young Women with Spina Bifida (#141)
Speaker: Christine Schafer
04:40 p.m. - 04:45 p.m.
Evaluation of Sexual Functions of Female Patients Using Systemic Retinoid for Acne Vulgaris Treatment (#142)
Speaker: Mehmet Gokhan Culha
04:45 p.m. - 04:50 p.m.
Randomized, Double-blind, Placebo-controlled Multicenter Study to Evaluate Efficacy and Safety of Ospemifene in Patients with Moderate to Severe Vaginal Dryness, Including Evaluation of Vulvar Health by Photographic Images (#143)
Speaker: Irwin Goldstein, MD
04:50 p.m. - 04:55 p.m.
Safety of Flibanserin in Women with Hypoactive Sexual Desire Disorder Taking Antidepressant Medications (#144)
Speaker: Anita Clayton
04:55 p.m. - 05:00 p.m.
Low Rates of Insomnia Associated with Flibanserin in Premenopausal Women with Hypoactive Sexual Desire Disorder (#145)
Speaker: Sharon Parish
05:00 p.m. - 05:05 p.m.
Conversations with Participants in the RECONNECT Studies About Their Experiences With Bremelanotide for Treatment of Hypoactive Sexual Desire Disorder (#146)
Speaker: Robin Pokrzywinsiki
05:05 p.m. - 05:10 p.m.
Premature Ejaculation and Female Sexual Dysfunction (#147)
Speaker: Ahmet Gokce, MD
05:10 p.m. - 05:15 p.m.
Evaluation of Female Sexual Dysfunction in Adult Entertainers (#148)
Speaker: Justin Dubin
05:15 p.m. - 05:20 p.m.
Would Ultra-low-dose Trazodone Treat HSDD Without Causing CNS Depression? (#149)
Speaker: Robert Pyke
05:20 p.m. - 05:25 p.m.
Sexual Dysfunction and Distress in Premenopausal Women with Migraine: Association with Depression, Anxiety and Migraine Related Disability (#150)
Speaker: Sefa Resim
05:25 p.m. - 05:30 p.m.
Milli™; the Only Patient Controlled Expanding Dilator: Results from the Initial Launch (#151)
Speaker: Michael Krychman, MD
04:00 p.m. - 05:30 p.m.
Location: Poinciana 3&4
Erectile Dysfunction (Medical) - Moderated Posters
Moderator: Seth Cohen, MD, MPH & Haocheng Lin, MD
04:10 p.m. - 04:15 p.m.
Variability in Cash Prices for Erectile Dysfunction Medications – Are All Pharmacies the Same? (#152)
Speaker: Kirtishri Mishra
04:15 p.m. - 04:20 p.m.
Preliminary Assessment on the Treatment of Erectile Dysfunction with Bimix Gel (#153)
Speaker: Daniel Martinez
04:20 p.m. - 04:25 p.m.
Is Statin Use at Time of Prostate Cancer Radiation Associated with Protection of Patient-reported Erectile Function? (#154)
Speaker: Esteban Chittester
04:25 p.m. - 04:30 p.m.
Pharmacokinetics of MED2005, a Topical Glyceryl Trinitrate Gel for the Treatment of Erectile Dysfunction (#155)
Speaker: Tim Holland
04:30 p.m. - 04:35 p.m.
Development of Nomograms to Predict Erectile Function After Radiation Therapy (#156)
Speaker: Helen Levey Bernie, DO, MPH
04:35 p.m. - 04:40 p.m.
Rethinking Prosthetic Solutions to Erectile Dysfunction (#157)
Speaker: Claire Apuan
04:40 p.m. - 04:45 p.m.
Penile Rehabilitation in the Long-term Follow-up – How Important is the Preservation of Nocturnal Penile Tumescense with Daily Low-dose Sildenafil 6 Weeks after Nerve-sparing Radical Prostatectomy? (#158)
Speaker: Andreas Bannowsky
04:45 p.m. - 04:50 p.m.
Two-year Cost Analysis of Penile Rehabilitation Post-prostatectomy for Various Regimens at a Single Institution (#159)
Speaker: Nelson Bennett, MD, FACS
04:50 p.m. - 04:55 p.m.
Predictors of Worsening Erectile Function in Men with Functional Erections Early After Radical Prostatectomy (#160)
Speaker: Helen Levey Bernie, DO, MPH
04:55 p.m. - 05:00 p.m.
A Phase II Randomized Trial to Evaluate Different Dose Regimens of Low-intensity Extracorporeal Shock Wave Therapy for Erectile Dysfunction (#161)
Speaker: Jonathan Katz
05:00 p.m. - 05:05 p.m.
Use of Radial Pulse Therapy and Nitric Oxide Boosting Supplement in the Treatment of ED (#162)
Speaker: Judson Brandeis
05:05 p.m. - 05:10 p.m.
Adherence and Outcomes with Penile Rehabilitation over a 2 Year Period (#163)
Speaker: Jeffrey Albaugh, PhD, APRN, CUCNS
05:10 p.m. - 05:15 p.m.
Generic Forms of Sildenafil Citrate Contain Impurities with Reduced or Absent Phosphodiesterase Type-5 (PDE5) Inhibition: A Global Survey (#164)
Speaker: Samuel Sherratt
05:15 p.m. - 05:20 p.m.
Impact of Penile Traction Therapy on Erectile Dysfunction in a Cohort of Men with Peyronie's Disease (#165)
Speaker: David Yang
05:20 p.m. - 05:25 p.m.
Analysis of Popular Erectile Dysfunction Supplements on Amazon.com (#166)
Speaker: Adithya Balasubramanian
05:25 p.m. - 05:30 p.m.
Improvement in SHIM Scores with the iNOS Stimulator, Revactin® (#167)
Speaker: Jacob Rajfer
Evening
05:30 p.m. - 06:30 p.m.
Location: Cowrie
Young Clinicians Mixer

Our Services

About SMSNA

Established in 1994, our objective has been to promote, encourage, and support the highest standards of practice, research, education, and ethics in the study of the anatomy, physiology, pathophysiology, diagnosis, and treatment...

~ Read More

Contact Us

SMSNA Executive Office
c/o Status Plus
+1 (952) 683 1917
+1 (952) 314 8212
info@smsna.org

Address
14305 Southcross Dr
Suite 100
Burnsville, MN 55306